Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18007394 | 1.00 | USP2 (0.36) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL17821128 | 0.92 | GPR84 (0.31) | GPR84FFAR1 | |
| SCHEMBL18007391 | 0.92 | GPR84 (0.31) | GPR84FFAR1 | |
| SCHEMBL8935620 | 0.82 | GPR84 (0.40) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL455822 | 0.82 | GPR84 (0.40) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL18007397 | 0.82 | CYP2C9 (0.31) | — | |
| SCHEMBL9753360 | 0.81 | GPR84 (0.37) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL29061780 | 0.81 | GPR84 (0.37) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL29061782 | 0.81 | GPR84 (0.37) | USP2GPR84FFAR1PLA2G2CCES2 | |
| SCHEMBL28892055 | 0.79 | LPAR5 (0.46) | LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106187734-A | The synthetic method of adipic acid | 现代自动车株式会社 | 2016-12-07 | — | — | CN | disclosed |
| US-9447012-B2 | Synthetic process of adipic acid | HYUNDAI MOTOR COMPANY (KR) | 2016-09-20 | — | — | US | disclosed |
| US-20160168065-A1 | NOVEL SYNTHETIC PROCESS OF ADIPIC ACID | HYUNDAI MOTOR COMPANY (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168065-A1 | NOVEL SYNTHETIC PROCESS OF ADIPIC ACID | FASN, GALK1, GRHPR | USP2 2304/4885GPR84 841/4885FFAR1 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.